# Effects of Orally Administered Beta-glucan on Leukocyte Function in Humans

> **NCT01727895** · NA · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 15 (actual)

## Conditions studied

- Immunologic Deficiency Syndromes

## Interventions

- **DIETARY_SUPPLEMENT:** Beta-glucan (Glucan #300®)

## Key facts

- **NCT ID:** NCT01727895
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2013-07
- **Final completion:** 2013-07
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2014-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01727895

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01727895, "Effects of Orally Administered Beta-glucan on Leukocyte Function in Humans". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01727895. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*